Covaxin
-
Bharat Biotech refused to supply more vaccine doses to Delhi citing Centre’s order, claims deputy CM
Scroll Staff
-
Coronavirus: 18 states getting direct supply of Covaxin since May 1, says Bharat Biotech
Scroll Staff
-
Covaxin’s IP rights shared between ICMR and Bharat Biotech, says research body chief
Scroll Staff
-
Covid-19: First batch of Sputnik V vaccines to arrive in India on May 1, says Russian official
Scroll Staff
-
Coronavirus: Maharashtra may see third wave of infections by July or August, says health minister
Scroll Staff
-
Covid-19: Covaxin price reduced to Rs 400 per dose from Rs 600 for states
Scroll Staff
-
Covid-19: Shortage stalls vaccination in Mumbai for 3 days, Maharashtra extends curbs till May 15
Scroll Staff
-
Explainer: The difference between vaccine efficacy and vaccine effectiveness – and why it matters
Sumedh MK
-
Coronavirus: Covaxin found to neutralise Indian variant, says Anthony Fauci
Scroll Staff
-
Delhi announces free Covid vaccines for all, Kejriwal urges manufacturers to bring down prices
Scroll Staff
-
Coronavirus: Maharashtra registers a dip in new cases as fewer tests reported
Scroll Staff
-
Whose intellectual property is Bharat Biotech’s publicly funded Covaxin? India deserves an answer
R Ramakumar
-
Coronavirus: With 3.49 lakh cases, India records highest daily rise for fourth day in a row
Scroll Staff
-
Coronavirus: UK, European Union, Germany offer help as India tackles rising infection count
Scroll Staff
-
Coronavirus: Covaxin priced at Rs 1,200 for private companies, Rs 600 for states
Scroll Staff
-
Covid vaccination: Registration for all adults to open on April 28
Scroll Staff
-
Coronavirus: Covaxin shows 78% efficacy in phase 3 interim analysis, says Bharat Biotech
Scroll Staff
-
Covishield vaccine to cost Rs 400 per dose for states, Rs 600 for private hospitals: Serum Institute
Scroll Staff
-
Coronavirus: Covaxin neutralises double mutant strain, other variants, says ICMR
Scroll Staff
-
Tamil actor Vivekh dies in Chennai at 59
Scroll Staff